China’s biotech boom: RAS-targeted drugs challenge US dominance
- Posted on July 8, 2026
- By South China Morning Post
- 0 Views
- 1 min read
China’s biotech boom: RAS-targeted drugs challenge US dominance
The rapid development of China’s RAS-targeted cancer drugs could reshape global oncology and unlock the country’s undervalued biotech firms.
